-
Albert J. Hunt, Jr., PhD, MBA
… Operations at Cogentis Therapeutics, Inc., Dr. Hunt has led multiple preclinical studies through industry and academic …
-
Dominick Auci, PhD
… at Brooklyn, scientific program manager at the National Multiple Sclerosis Society, and manager of Biomedical …
-
Generating and Characterizing LRRK2 Antibodies
… normal and Parkinson’s cellular function. MJFF is funding multiple groups to develop therapies against LRRK2 that, if … selection of one or several antibodies that perform well in multiple different methodologies, and these will then be …
-
PROGENI Family Study
… We have previously recruited over 800 families having multiple members diagnosed with PD. About 5% of these … In addition, we will also recruit control families having multiple members with PD, but who do not have a LRRK2 …
-
Development of Novel Brain-penetrant Inflammasome Inhibitors as Potential Therapeutics for Parkinson’s Disease
… Study Rationale: The immune system displays an aberrant pattern of activity in the central nervous system of people with Parkinson’s disease (PD); this pattern … Although short-term activation of the immune system can be beneficial in fighting infections or healing …
-
Toshiya Nishi, DVM
… During his career as a pharmacologist, Dr. Nishi has led multiple drug discovery programs in diverse therapeutic …